Robert Silver - IShares Insurance Independent Trustee
| IAK Etf | USD 136.03 1.14 0.85% |
Mr. Robert H. Silver is an Independent Trustee of iShares Dow Jones U.S. Insurance Index Fund., since 2007. Mr. Silver has served as a Trustee of iShares Trust since 2007 and a Director of iShares MSCI Russia Capped Index Fund, Inc. since 2010. Mr. Silver is President and a cofounder of The Bravitas Group Inc., a firm dedicated to advising and investing in emerging business enterprises and to supporting philanthropic activities that benefit underserved urban youth. Previously, Mr. Silver served as the President and Chief Operating Officer of UBS Financial Services Inc., the registered broker dealer comprising the Management USA business unit of UBS AG. Mr. Silver served on the Board of Directors of EPAM, a provider of software engineering outsourcing services in Central and Eastern Europe, the Depository Trust and Clearing Corporation and served as a governor of the Philadelphia Stock Exchange. In addition, Mr. Silver is a Vice Chairman and a Member of the Board of Directors for the YMCA of Greater New York and chairs its Fund Development Committee since 2001 and CoFounder and Vice President of Parentgiving Inc. since 2008. Mr. Silver began his career as a CPA at KPMG LLP from 1983 until 1997
| Age | 57 |
| Tenure | 17 years |
| Issuer | iShares |
| Inception Date | 2006-05-01 |
| Benchmark | Dow Jones U.S. Select Insurance Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 768.55 Million |
| Average Trading Valume | 56,221.6 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Financials |
| Market Concentration | Developed Markets |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| John Kerrigan | iShares Regional Banks | 60 | |
| Cecilia Herbert | iShares Pharmaceuticals ETF | 67 | |
| Frank Nesvet | SPDR SP Insurance | 68 | |
| Scott Zoltowski | SPDR SP Insurance | 43 | |
| Robert Kapito | iShares Broker Dealers Securiti | 62 | |
| Charles Hurty | iShares Pharmaceuticals ETF | 72 | |
| John Martinez | iShares Financial Services | 55 | |
| Madhav Rajan | iShares Pharmaceuticals ETF | 52 | |
| Mary Zeven | SPDR SP Insurance | 51 | |
| Charles Hurty | iShares Regional Banks | 72 | |
| John Martinez | iShares Pharmaceuticals ETF | 55 | |
| Eilleen Clavere | iShares Financial Services | 60 | |
| George Parker | iShares Financial Services | 80 | |
| John Martinez | iShares Regional Banks | 55 | |
| Madhav Rajan | iShares Broker Dealers Securiti | 52 | |
| Helen Peters | SPDR SP Insurance | 71 | |
| Eilleen Clavere | iShares Regional Banks | 60 | |
| John Kerrigan | iShares Financial Services | 60 | |
| Charles Hurty | iShares Financial Services | 72 | |
| Cecilia Herbert | iShares Financial Services | 67 | |
| Robert Kapito | iShares Pharmaceuticals ETF | 62 | |
iShares Insurance ETF Money Managers
| Geoffrey Flynn, Chief Operating Officer, Executive Vice President | ||
| Robert Silver, Independent Trustee | ||
| John Kerrigan, Independent Trustee | ||
| Madhav Rajan, Independent Trustee | ||
| Matt Tucker, Vice President | ||
| Cecilia Herbert, Independent Trustee | ||
| Michael Latham, President Director | ||
| Jack Gee, Chief Financial Officer, Treasurer | ||
| Charles Hurty, Independent Trustee | ||
| Eilleen Clavere, Secretary | ||
| George Parker, Independent Chairman of the Board of Trustee | ||
| John Martinez, Independent Trustee | ||
| Amy Schioldager, Executive Vice President | ||
| Robert Kapito, Trustee | ||
| Ira Shapiro, Vice President Chief Legal Officer |
IShares Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IShares Insurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | 14.24 X | |||
| Price To Book | 1.08 X | |||
| Price To Sales | 1.15 X | |||
| Number Of Employees | 15 | |||
| Beta | 0.62 | |||
| Total Asset | 308.05 M | |||
| One Year Return | 40.00 % | |||
| Three Year Return | 19.90 % | |||
| Five Year Return | 16.20 % | |||
| Ten Year Return | 12.70 % |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Insurance ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
The market value of iShares Insurance ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Insurance's value that differs from its market value or its book value, called intrinsic value, which is IShares Insurance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Insurance's market value can be influenced by many factors that don't directly affect IShares Insurance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Insurance's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Insurance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Insurance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.